Circulation

FEBRUARY 22, 2024

Over the past decade, new research has advanced scientific knowledge of neurodevelopmental trajectories, factors that increase neurodevelopmental risk, and neuroprotective strategies for individuals with congenital heart disease.

Congenital Heart Disease 75

Congenital Heart Disease Congenital Heart Disease Genetic predisposition 75

Frontiers in Cardiovascular Medicine

MARCH 28, 2025

IntroductionVentricular septal defect (VSD) is a common congenital heart disease (CHD), accounting for 2030% of all CHD cases. Procedural success, complications, and follow-up outcomes were assessed at 1, 3, 12, and 18 months post-procedure. Data were analyzed using SPSS 20.0.ResultsThe

VSD 52

VSD Outcomes Congenital Heart Disease Aortic valve 52

Journal of the American Heart Association

SEPTEMBER 12, 2024

Due to improvements in recognition and management of their multisystem disease, the long‐term survival of infants, children, and adolescents with trisomy 21 and congenital heart disease now matches children with congenital heart disease and no genetic condition in many scenarios.

Congenital Heart Disease 71

Congenital Heart Disease Congenital Heart Disease Quality of Life 71

Heart BMJ

SEPTEMBER 25, 2024

Congenital heart defects are the most common type of birth defect, affecting 1% of live births. The underlying cause of congenital heart disease is frequently unknown. However, genetic testing and counselling indications can be challenging to identify in clinical practice.

Congenital Heart Disease 59

Congenital Heart Disease Congenital Heart Disease Document 59

DAIC

JANUARY 6, 2025

6, 2025 Medtronic plc hasannounced it received CE ( Conformit Europenne ) Mark for the Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT).

Pulmonary 52

Pulmonary Congenital Heart Disease Open-Heart Surgery Congenital 52

Frontiers in Cardiovascular Medicine

FEBRUARY 23, 2025

BackgroundCongenital heart disease (CHD) is a major contributor to morbidity and infant mortality and imposes the highest burden on global healthcare costs. Early diagnosis and prompt treatment of CHD contribute to enhanced neonatal outcomes and survival rates; however, there is a shortage of proficient examiners in remote regions.

Congenital Heart Disease 52

Congenital Heart Disease Heart Disease Ultrasound Congenital 52

American College of Cardiology

JUNE 4, 2024

addressed the safety, tolerability, and outcomes of patients with adult congenital heart disease (ACHD) treated with sodium-glucose cotransporter 2 inhibitors (SGLT2i). Neijenhuis et al. and Fusco et al.

Congenital Heart Disease 58

Congenital Heart Disease Congenital Heart Disease Outcomes 58

American College of Cardiology

MARCH 11, 2024

The following are key points to remember from an American Heart Association Scientific Statement on neurodevelopmental outcomes for individuals with congenital heart disease, which includes updates in neuroprotection, risk-stratification, evaluation, and management.

Congenital Heart Disease 48

Congenital Heart Disease Congenital Heart Disease Outcomes 48

Circulation

JANUARY 27, 2025

METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.

Heart Disease 81

Heart Disease Peripheral Arterial Disease Stroke Strokes 81

Frontiers in Cardiovascular Medicine

JULY 22, 2024

It will also discuss the clinical applications of MRI in diagnosing and monitoring placental insufficiency, as well as its implications for fetal growth restriction (FGR) and congenital heart disease (CHD).

Congenital Heart Disease 59

Congenital Heart Disease Congenital Heart Disease Biomarkers 59

Journal of Cardiothoracic Surgery

FEBRUARY 9, 2024

Adult patients surviving with congenital heart disease (ACHD) is growing. We examine the factors associated with heart transplant outcomes in this challenging population with complex anatomy requiring redo-sur.

Congenital Heart Disease 52

Congenital Heart Disease Heart Transplant Transplant Congenital 52

Frontiers in Cardiovascular Medicine

JANUARY 22, 2025

The primary outcome was survival at the follow-up evaluation. The time point designated as time 0 was defined as the time of heart transplantation. A higher mortality rate was observed among children under three months of age with congenital heart disease.

Heart Transplant 52

Heart Transplant Transplant Pediatrics Heart Failure 52

Conquering CHD

JANUARY 16, 2024

This was a bold move at the time, when most patients with his congenital heart condition — dextro-transposition of the great arteries, or d-TGA — were advised to avoid exercise and strenuous activity. News & World Report, the Heart Institute cares for all congenital and childhood heart diseases.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease Quality of Life 52

Conquering CHD

JUNE 20, 2023

Congenital heart disease is a daunting diagnosis for any parent. We’ll cover common types of medications used to treat congenital heart disease, what parents should know about their use, and potential side effects to watch out for. Be sure to talk to your doctor if you have any questions or concerns.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease ACE Inhibitor 52

Circulation

MAY 29, 2024

With continued medical and surgical advancements, most children and adolescents with congenital heart disease are expected to survive to adulthood. Circulation, Ahead of Print.

Congenital Heart Disease 45

Congenital Heart Disease Heart Failure Congenital Heart Disease 45

HeartRhythm

APRIL 30, 2024

Outcomes data of catheter ablation (CA) for atrial tachyarrhythmias (AT) in the congenital heart disease (CHD) population are largely drawn from single center studies.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Ablation 40

Medical Xpress - Cardiology

MARCH 19, 2025

Adult patients with congenital heart disease (CHD) have poor exercise capacity, which is associated with adverse outcomes.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Exercise Heart Disease 40

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

BackgroundAs a minimally invasive approach to treating congenital heart disease (CHD), the application of the right subaxillary small incision (RSSI) has been developing fast in its indication spectrum. The infants were divided into the RSSI group and the median sternotomy (MS) group.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease ICU 52

Medical Xpress - Cardiology

FEBRUARY 22, 2024

More than a decade of new knowledge about neurodevelopmental risk in people with congenital heart disease has changed the thinking about who is most at risk and the factors that impact neurological development, learning, emotions and behaviors, according to a new American Heart Association statement published in Circulation.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Research 40

Open Heart

JANUARY 29, 2024

Objective This study aimed to explore clinicians’ perspectives of ambulatory care in adult congenital heart disease (ACHD). The concerned clinicians raise the question whether increasing resource alone without changing structure will lead to better outcomes for patients.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease Outpatient 52

Journal of Cardiovascular Electrophysiology

JANUARY 24, 2025

ABSTRACT Introduction Data regarding safety and long-term outcome of very high-power-short duration (vHPSD) ablation in adult congenital heart disease (ACHD) patients with paroxysmal or persistent atrial fibrillation (AF) are lacking. Methods Retrospective observational single-center study.

Congenital Heart Disease 40

Congenital Heart Disease Atrial Fibrillation Congenital Ablation 40

Journal of the American Heart Association

FEBRUARY 29, 2024

BackgroundNeonates with congenital heart disease are at risk for impaired brain development in utero, predisposing children to postnatal brain injury and adverse long‐term neurodevelopmental outcomes. We applied a placental pathology severity score to relate placental abnormalities to neurological outcome.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Outcomes 40

Frontiers in Cardiovascular Medicine

FEBRUARY 2, 2024

Aims A proportion of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) do not fit in the current classification.

Congenital Heart Disease 64

Congenital Heart Disease Congenital Pulmonary Hypertension 64

Open Heart

DECEMBER 11, 2022

Objective To bring together patients, parents, charities and clinicians in a Priority Setting Partnership to establish national clinical priorities for research in children and adults with congenital heart disease. In a second survey, respondents identified the unanswered questions most important to them.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Research 40

Circulation

NOVEMBER 11, 2024

Variations in cardiogenic shock, MCS usage, and cardiac transplants emphasize the need for adaptive clinical practices to optimize patient outcomes.

Cardiogenic Shock 40

Cardiogenic Shock Congenital Heart Disease Heart Failure Congenital 40

Circulation: Cardiovascular Interventions

NOVEMBER 6, 2023

Background:Neonates with complex congenital heart disease and pulmonary overcirculation have been historically treated surgically. However, subcohorts may benefit from less invasive procedures. kilograms [IQR, 2.1–3.3])

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pulmonary 40

Circulation: Cardiovascular Interventions

JANUARY 23, 2024

This study aims to develop a risk adjustment methodology introducing a novel, clinically meaningful adverse event outcome and incorporating a modern understanding of risk.METHODS:Data from diagnostic only and interventional cases with defined case types were collected for patients ≤18 years of age and ≥2.5

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pediatrics 40

Journal of the American Heart Association

NOVEMBER 29, 2023

BackgroundLittle is known about outcomes following heart failure (HF) hospitalization among adults with congenital heart disease (CHD) in the United States.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Failure Heart Disease 40

Journal of Cardiovascular Electrophysiology

DECEMBER 8, 2023

Abstract Introduction Cardiac resynchronization therapy (CRT) is a standard treatment for patients with heart failure with reduced ejection fraction. However, there is still a gap of evidence in congenital heart disease (CHD) patients regarding resynchronization therapy.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Outcomes 40

Frontiers in Cardiovascular Medicine

APRIL 7, 2024

Advances in pediatric cardiac surgery have resulted in a recent growing epidemic of children and young adults with congenital heart diseases (CHDs). In these patients, congenital defects themselves, surgical operations and remaining lesions may alter cardiac anatomy and impact the mechanical performance of both ventricles.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Anatomy 40

Stroke Journal

FEBRUARY 1, 2024

We investigated the incidence of stroke and transient ischemic attack (TIA) in adults with congenital heart disease (ACHD).Methods:A Two independent reviewers screened studies, which were included if patients were age 16 and older with congenital heart disease, and if the outcome was stroke or TIA.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Stroke 40

Conquering CHD

JANUARY 17, 2025

Zeke and Zane were both diagnosed with hypoplastic left heart syndrome (HLHS) before birth. As far as congenital heart diseases go, HLHS falls on the rarer end of the spectrum. News & World Report, the Heart Institute cares for all congenital and childhood heart diseases.

Heart Transplant 98

Heart Transplant Transplant Open-Heart Surgery Nursing 98

Open Heart

JANUARY 11, 2023

Objectives To evaluate bare-metal Optimus and polytetrafluoroethylene (PTFE)-covered Optimus-CVS balloon-expandable, cobalt–chromium, hybrid cell–designed stents in congenital heart disease (CHD) interventions. Stent mechanical behaviour, clinical indications and outcomes were assessed. XXL/15-ZIG, 33.3%

Congenital Heart Disease 40

Congenital Heart Disease Stent Stents Congenital 40

Journal of the American Heart Association

FEBRUARY 14, 2024

Journal of the American Heart Association, Ahead of Print. BackgroundGaps in care (GIC) are common for patients with congenital heart disease (CHD) and can lead to worsening clinical status, unplanned hospitalization, and mortality. Several SDOH, including a low COI, were associated with GIC.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Education 40

Circulation: Cardiovascular Interventions

NOVEMBER 9, 2023

The purpose of this study was to evaluate cardiac reverse remodeling and temporal changes in heart failure indices after TT-VIVR in adults with congenital heart disease.Methods:Retrospective cohort study of adults with congenital heart disease that underwent TT-VIVR and had >6 months of follow-up (January 1, 2011, to April 30, 2023).

Congenital Heart Disease 40

Congenital Heart Disease Tricuspid Heart Failure Congenital 40

Society of Thoracic Surgeons - Adult Cardiac

SEPTEMBER 24, 2024

Video Latin Heart Rounds: Tetralogy of Fallot Update kchalko Tue, 09/24/2024 - 16:04 This video is based on the Latin Heart Rounds webinar series on the current management of patients with tetralogy of Fallot, including neonates and on the current short and long term outcomes for this congenital heart disease.

Webinar 59

Webinar Congenital Heart Disease Congenital Heart Disease 59

Journal of Cardiothoracic Surgery

OCTOBER 2, 2024

"Swiss Cheese" ventricular septal defects represent a serious congenital heart disease with suboptimal clinical outcomes and a lack of consensus regarding its management. This study presents mid-term follow-up.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease Outcomes 52